期刊文献+

乳腺癌非前哨淋巴结转移的相关危险因素分析 被引量:7

Analysis of related risk factors for non-sentinel lymph node metastasis in breast cancer
原文传递
导出
摘要 目的:探讨前哨淋巴结活检(SLNB)阳性乳腺癌患者非前哨淋巴结(NSLN)转移的危险因素。方法:收集2009年7月—2013年10月新疆医科大学附属肿瘤医院收治的138例SLNB阳性的乳腺癌患者临床资料,采用单因素及多因素Logistic回归分析方法研究各项临床病理因素与NSLN转移的关系。结果:单因素分析显示,原发肿瘤直径、组织学分级、前哨淋巴结转移率、前哨淋巴结转移灶最大径及脉管浸润与NSLN转移有关(均P<0.05);多因素Logistic回归分析发现,原发肿瘤直径(OR=2.263,P=0.005)、前哨淋巴结转移率(OR=1.919,P=0.002)、前哨淋巴结转移灶最大径(OR=8.479,P=0.000)、脉管浸润(OR=4.518,P=0.029)是NSLN转移的独立危险因素。结论:原发肿瘤直径、前哨淋巴结转移率、前哨淋巴结转移灶最大径及脉管浸润可作为预测乳腺癌NSLN转移的独立性指标。 Objective: To investigate the risk factors for non-sentinel lymph node (NSLN) metastasis in breast cancer patients with positive sentinel lymph node biopsy (SLNB) results.Methods: The clinical data of 138 breast cancer patients with positive SLNB results admitted from July 2009 to October 2013 at the affiliated tumor hospital of Xinjiang Medical University were collected. The relations of the clinicopathologic factors with NSLN metastasis were determined by univariate and multivariate Logistic regression analysis.Results: Univariate analysis showed that primary tumor diameter, histological grade, rate of sentinel lymph node metastases, maximal diameter of the sentinel lymph node metastases and vessel invasion were related to NSLN metastasis (all P〈0.05); Logistic regression analysis identified that primary tumor diameter (OR=2.263, P=0.005), rate of sentinel lymph node metastases (OR=1.919, P=0.002), maximal diameter of the sentinel lymph node metastases (OR=8.479, P=0.000) and vessel invasion (OR=4.518, P=0.029) were independent risk factors for NSLN metastasis.Conclusion: Primary tumor diameter, rate of sentinel lymph node metastases, maximal diameter of the sentinel lymph node metastases, and vessel invasion can be used as independent variables to predict NSLN metastasis in breast cancer patients.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2014年第5期661-664,共4页 China Journal of General Surgery
关键词 乳腺肿瘤 前哨淋巴结活组织检查 危险因素 Breast Neoplasms Sentinel Lymph Node Biopsy Risk Factors
  • 相关文献

参考文献19

二级参考文献94

  • 1李振平,李占文,胡云锵,刘纯,杨华峰,王雯,杨海涛,陈冬,徐亚军,周尚燕.乳腺癌前哨淋巴结活检的临床探讨[J].中国肿瘤临床,2005,32(12):681-683. 被引量:4
  • 2申郑堂,欧慧英,邬玉辉,海健,王守满.乳腺癌前哨淋巴结检出率的影响因素[J].中国普通外科杂志,2005,14(9):708-710. 被引量:10
  • 3张保宁,邵志敏,乔新民,李波,姜军,杨名添,王水,宋三泰,张斌,杨红健.中国乳腺癌保乳治疗的前瞻性多中心研究[J].中华肿瘤杂志,2005,27(11):680-684. 被引量:247
  • 4王永胜,左文述,刘娟娟,于志勇,刘岩松,李永清,周正波,刘雁冰,李济宇,赵桐,陈鹏.乳腺癌前哨淋巴结活检替代腋窝清扫术前瞻性非随机对照临床研究[J].外科理论与实践,2006,11(2):104-107. 被引量:32
  • 5Goyal A, Horgan K, Kissin M, et al. Sentinel lymph node biop- sy in male breast cancer patients [J]. Eur J Surg Oncol, 2004, 30(5):480-483. 被引量:1
  • 6van Rijk MC, Nieweg OE, Rutgers EJ,et al. Sentinel node biop- sy before neoadjuvant chemotherapy spares breast cancer pa- tients axillary lymph node dissection [J]. Ann Surg Oncol, 2006, 13(10):475-479. 被引量:1
  • 7Newman ES, Diehl KM, Cimmino VM, et al. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accu- rate in patients with documented node-positive disease at pre- sentation[J]. Ann Surg 0ncol,2007, 14(10):2946-2952. 被引量:1
  • 8Mamounas EP, Brown A, Anderson S, et al. Sentinel node biop- sy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Pro- toeol B-27[J]. J Clin Oncol,2005, 23(12):2694-2702. 被引量:1
  • 9Kang SH, Kim SK, Kwon Y, et al. Decreased Identification Rate of Sentinel Lymph Node afier Neoadjuvant Chemotherapy [J]. World J Surg, 2004,28(10):1019. 被引量:1
  • 10Boughey JC, Hunt KK. Expanding the indications for sentinel lymph node surgery in breast cancer[J].Future Oncology,2007,3 (1):9-14. 被引量:1

共引文献46

同被引文献36

引证文献7

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部